ElevateBio Appoints Larry Lockwood, Ph.D., as Chief Commercial Officer Dr. Lockwood brings more than 20 years of experience driving revenue growth and establishing global partnerships for manufacturing and research organizations GlobeNewswire September 08, 2025 WALTHAM, Mass., Sept. 08, 2025 (GLOBE NEWSWIRE) — ElevateBio, a technology-driven company focused on powering the creation of life-transforming genetic medicines, […]

Angitia Biopharmaceuticals Presents First-in-Human Data on AGA2115 for Osteogenesis Imperfecta at ASBMR 2025 GlobeNewswire September 08, 2025 • Clinical data demonstrated administration of AGA2115 drove dose-dependent increases in bone mineral density • The Company and collaborators also presented data from non-human primate and mouse models WESTLAKE VILLAGE, Calif., Sept. 08, 2025 (GLOBE NEWSWIRE) — Angitia

Xtract One Selected by Delmar School District for Enhanced Security Solutions Shared Middle and High School Building to Deploy Xtract One Gateway to Secure Entrances & Foster a Welcoming Educational Environment GlobeNewswire September 08, 2025 TORONTO, Sept. 08, 2025 (GLOBE NEWSWIRE) — Xtract One Technologies (TSX: XTRA) (OTCQX: XTRAF) (FRA: 0PL) (“Xtract One” or the

Humanoid Global Announces Strategic Investment in RideScan, a Pioneer Advancing AI for Robotics Safety and Performance – NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES – GlobeNewswire September 08, 2025 Vancouver, BC & Edinburgh, Scotland, Sept. 08, 2025 (GLOBE NEWSWIRE) — Humanoid Global Holdings Corp. (“Humanoid Global” or the “Company“) (CSE:ROBO,

Sparton Resources Inc. Pense Critical Metals Project Exploration Permits Received New Massive Sulphide Mineralization Found GlobeNewswire September 08, 2025 TORONTO, Sept. 08, 2025 (GLOBE NEWSWIRE) — Sparton Resources Inc. (TSXV-SRI) (“Sparton” or the “Company“) announced today that field operations are underway at the Pense Critical Metals Project near Englehart in Northern Ontario and Quebec. The

Revival Gold Progresses Drilling and Development Activities at Mercur GlobeNewswire September 08, 2025 TORONTO, Sept. 08, 2025 (GLOBE NEWSWIRE) — Revival Gold Inc. (TSXV: RVG, OTCQX: RVLGF) (“Revival Gold” or the “Company”) is pleased to provide an update on drilling and development activities at the Company's Mercur Gold Project (“Mercur” or, the “Project”) located in

PharmaCorp to Acquire a Pharmacy in Ontario for $5,300,000, New Non-Binding Letter of Intent to Acquire Two Pharmacies in Eastern Canada, Updates on Previously Announced Non-Binding Letters of Intent and Filing of Q2 Investor Presentation GlobeNewswire September 08, 2025 SASKATOON, Saskatchewan, Sept. 08, 2025 (GLOBE NEWSWIRE) — PHARMACORP RX INC. (“PharmaCorp” or the “Corporation“) (TSXV:

FTI Consulting Appoints Shaun Rangappa, MD, MSHA, as Chief Clinical Executive and Senior Managing Director in Healthcare Business Transformation Practice GlobeNewswire September 08, 2025 WASHINGTON, Sept. 08, 2025 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced the appointment of Shaun Rangappa, MD, MSHA, as a Senior Managing Director in the Healthcare Business Transformation

TG Announces Phase 3 Trial for Subcutaneous BRIUMVI Commenced Enrollment Phase 3 trial to evaluate two subcutaneous BRIUMVI dosing regimens GlobeNewswire September 08, 2025 NEW YORK, Sept. 08, 2025 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (NASDAQ: TGTX), announced today that enrollment has commenced in a Phase 3 trial evaluating subcutaneous BRIUMVI (ublituximab-xiiy), the company's anti-CD20

NEW YORK, NY / ACCESS Newswire / September 8, 2025 / If you suffered a loss on your Novo Nordisk A/S (NYSE:NVO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/novo-nordisk-a-s-lawsuit-submission-form-3?prid=165852&wire=1&utm_campaign=21 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or